Search research articles
Contact Us
Filters
Showing results (121-130 of 150) with videos related to
Page
of 15
Sort By:
Plos Pathogens
|
June 20, 2024
The role of socio-economic disparities in the relative success and persistence of SARS-CoV-2 variants in New York City in early 2021
Tetyana I Vasylyeva, Jennifer L Havens, Jade C Wang, et al.
Pediatrics
|
June 1, 1993
Measles severity and serum retinol (vitamin A) concentration among children in the United States
J C Butler, P L Havens, A L Sowell, et al.
Frontiers in Genetics
|
December 3, 2013
Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein
Travis R Porter, Xuelin Li, Charles B Stephensen, et al.
The Journal of Allergy and Clinical Immunology
|
July 1, 1994
A cluster of anaphylactic reactions in children with spina bifida during general anesthesia: epidemiologic features, risk factors, and latex hypersensitivity
K J Kelly, M L Pearson, V P Kurup, et al.
AIDS Research and Human Retroviruses
|
October 4, 2018
Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis
Peter L Havens, Ashutosh Tamhane, Charles B Stephensen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2019
Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113
Peter L Havens, Suzanne E Perumean-Chaney, Amit Patki, et al.
The Journal of Infectious Diseases
|
June 30, 2022
Introduction and Establishment of SARS-CoV-2 Gamma Variant in New York City in Early 2021
Tetyana I Vasylyeva, Courtney E Fang, Michelle Su, et al.
Viruses
|
July 22, 2010
Epidemiologic Observations from Passive and Targeted Surveillance during the First Wave of the 2009 H1N1 Influenza Pandemic in Milwaukee, WI
Swati Kumar, Michael J Chusid, Rodney E Willoughby, et al.
Antimicrobial Agents and Chemotherapy
|
November 21, 2007
Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection
Jennifer J Kiser, Courtney V Fletcher, Patricia M Flynn, et al.
Antimicrobial Agents and Chemotherapy
|
July 16, 2008
Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors
Brian L Robbins, Edmund V Capparelli, Ellen G Chadwick, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 150) with videos related to
Sort By:
Page
of 15
Plos Pathogens
|
June 20, 2024
The role of socio-economic disparities in the relative success and persistence of SARS-CoV-2 variants in New York City in early 2021
Tetyana I Vasylyeva, Jennifer L Havens, Jade C Wang, et al.
Pediatrics
|
June 1, 1993
Measles severity and serum retinol (vitamin A) concentration among children in the United States
J C Butler, P L Havens, A L Sowell, et al.
Frontiers in Genetics
|
December 3, 2013
Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein
Travis R Porter, Xuelin Li, Charles B Stephensen, et al.
The Journal of Allergy and Clinical Immunology
|
July 1, 1994
A cluster of anaphylactic reactions in children with spina bifida during general anesthesia: epidemiologic features, risk factors, and latex hypersensitivity
K J Kelly, M L Pearson, V P Kurup, et al.
AIDS Research and Human Retroviruses
|
October 4, 2018
Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis
Peter L Havens, Ashutosh Tamhane, Charles B Stephensen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2019
Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113
Peter L Havens, Suzanne E Perumean-Chaney, Amit Patki, et al.
The Journal of Infectious Diseases
|
June 30, 2022
Introduction and Establishment of SARS-CoV-2 Gamma Variant in New York City in Early 2021
Tetyana I Vasylyeva, Courtney E Fang, Michelle Su, et al.
Viruses
|
July 22, 2010
Epidemiologic Observations from Passive and Targeted Surveillance during the First Wave of the 2009 H1N1 Influenza Pandemic in Milwaukee, WI
Swati Kumar, Michael J Chusid, Rodney E Willoughby, et al.
Antimicrobial Agents and Chemotherapy
|
November 21, 2007
Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection
Jennifer J Kiser, Courtney V Fletcher, Patricia M Flynn, et al.
Antimicrobial Agents and Chemotherapy
|
July 16, 2008
Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors
Brian L Robbins, Edmund V Capparelli, Ellen G Chadwick, et al.
Page
of 15